TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
GHRS

GH Research PLC

Healthcare · Biotechnology

23.50$ -4.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GHRS
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 100.0% 100.0% 66.3% 72.5% 81.9% 99.2%
98.8% 99.7% 98.9% 65.2% 34.7% 53.5% 85.4%
98.8% 99.7% 98.9% 65.2% 71.4% 79.3% 97.4%
– 0.1% 0.0% 0.0% 0.1% 0.9% 0.4%
– -0.1% 1.1% 0.0% -0.1% – –
– – 0.0% 0.0% – – –
20.6% 4.2% 1.0% 1.8% 3.2% 5.0% 3.0%
20.6% 4.2% 1.0% 1.8% 3.0% 4.8% 2.9%
– – – – 0.2% 0.1% 0.1%
18.5% 0.0% 0.3% 0.7% 1.5% 2.0% 1.3%
79.4% 95.8% 99.0% 98.2% 96.8% 95.0% 97.0%
-77.2% -14.1% -3.6% -12.8% -30.0% -56.5% -53.6%
5,555.6% 513.7% 18.6% 20.5% 23.0% 27.6% 21.2%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?